Patient Health Questionnaire-9 (PHQ-9) Psychiatric Evaluation and Evidence-Based Rating Scale
Psychiatric Evaluation Tool selected: PHQ-9
The psychiatric interview is the foundation of psychiatric assessment and diagnosis. Three important components of the psychiatric interview are the history of present illness, the mental status examination, and the risk assessment. According to Kilian et al. (2020), the history of present illness provides a detailed understanding of the client’s current symptoms, including onset, duration, severity, precipitating factors, and the impact on daily functioning. This information helps the clinician identify symptom patterns and formulate differential diagnoses (Kilian et al., 2020). The mental status examination offers a structured evaluation of the client’s appearance, behavior, mood, affect, thought processes, cognition, insight, and judgment. It provides objective data that complement the client’s subjective report. Risk assessment is equally essential because it evaluates the presence of suicidal ideation, self-harm behaviors, homicidal thoughts, and other safety concerns (Ryan & Oquendo, 2020). Together, these components provide a comprehensive understanding of the client’s psychological functioning, establish diagnostic accuracy, and guide treatment planning. Without a thorough evaluation of these areas, important clinical information may be overlooked, potentially compromising patient safety and treatment outcomes.
The history of present illness is particularly important because psychiatric symptoms often overlap across multiple disorders. A detailed exploration of symptom characteristics allows the psychiatric nurse practitioner to distinguish between conditions such as major depressive disorder, generalized anxiety disorder, bipolar disorder, and adjustment disorders. The mental status examination is equally valuable because it captures observable clinical findings that may not be revealed during routine questioning. For example, psychomotor retardation, impaired concentration, or flattened affect may provide evidence supporting a diagnosis of depression. Risk assessment remains a critical component because psychiatric conditions frequently involve safety concerns that require immediate intervention. Early identification of suicidal ideation or intent allows clinicians to implement protective measures and appropriate treatment strategies (Brenner et al., 2020). These interview components work together to improve diagnostic accuracy and facilitate evidence-based decision making. According to the American Psychiatric Association, a comprehensive psychiatric evaluation that includes symptom history, mental status assessment, and safety evaluation is essential for accurate diagnosis and effective treatment planning in mental health practice.
GET CLASS HELP
The Patient Health Questionnaire-9 (PHQ-9) is a widely used, evidence-based screening and monitoring instrument designed to assess depressive symptoms (Beswick et al., 2022). The scale consists of nine items that correspond directly to the diagnostic criteria for major depressive disorder outlined in the Diagnostic and Statistical Manual of Mental Disorders. Clients rate the frequency of symptoms experienced during the previous two weeks using a four-point scale ranging from 0, meaning “not at all,” to 3, meaning “nearly every day.” Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. The PHQ-9 demonstrates strong psychometric properties, making it a reliable and valid instrument for clinical practice. Levis et al. (2020) reported a sensitivity and specificity of 88% for major depression when using a cutoff score of 10. The instrument also demonstrates excellent internal consistency, with studies reporting Cronbach’s alpha values typically exceeding 0.80. Furthermore, the PHQ-9 has demonstrated strong construct validity and criterion validity across diverse populations and healthcare settings, supporting its widespread use in psychiatric assessment (Levis et al., 2020)
The PHQ-9 is most appropriately used during the psychiatric interview when depression is suspected or when depressive symptoms are being monitored over time. It is particularly useful during initial evaluations, routine mental health screenings, and follow-up visits to assess treatment response. Because the instrument is brief, easy to administer, and easily understood by most clients, it can be completed before or during the interview process without significantly increasing assessment time. The scale is also valuable in primary care, psychiatric clinics, and telehealth settings where efficient screening methods are needed. Item nine of the PHQ-9 assesses thoughts of death or self-harm, providing clinicians with an opportunity to explore suicide risk further when indicated (Kim et al., 2021). While the PHQ-9 should not be used as the sole basis for diagnosis, it serves as an important adjunct to clinical judgment and comprehensive psychiatric evaluation. Positive findings should always be followed by a more detailed clinical assessment to confirm diagnosis and determine appropriate interventions.
The PHQ-9 is helpful to the psychiatric nurse practitioner’s assessment because it provides a standardized and objective measure of depressive symptom severity. Standardized tools reduce variability in assessment practices and allow clinicians to compare symptom levels across visits. The scale supports clinical decision making by identifying symptom severity categories, including minimal, mild, moderate, moderately severe, and severe depression. These categories can help guide treatment recommendations and determine the need for psychotherapy, pharmacotherapy, or referral for specialized services. Additionally, repeated administration of the PHQ-9 allows clinicians to monitor treatment effectiveness and document clinical improvement or worsening symptoms over time (Kendrick et al., 2024). Research has consistently demonstrated that measurement-based care improves outcomes for individuals with depression, and the PHQ-9 is one of the most commonly recommended instruments for this purpose (He et al., 2024). By combining information obtained from the psychiatric interview with data from the PHQ-9, psychiatric nurse practitioners can develop more accurate diagnoses, establish baseline symptom severity, evaluate treatment response, and provide evidence-based, patient-centered care (Teusen et al., 2022).
References
Beswick, E., Quigley, S., Macdonald, P., Patrick, S., Colville, S., Chandran, S., & Connick, P. (2022). The Patient Health Questionnaire (PHQ-9) as a tool to screen for depression in people with multiple sclerosis: a cross-sectional validation study. BMC Psychology, 10(1). https://doi.org/10.1186/s40359-022-00949-8Links to an external site..
Brenner, J. M., Marco, C. A., Kluesner, N. H., Schears, R. M., & Martin, D. R. (2020). Assessing psychiatric safety in suicidal emergency department patients. Journal of the American College of Emergency Physicians Open, 1(1), 30–37. https://doi.org/10.1002/emp2.12017Links to an external site..
He, Y., Wang, X., Wang, Z., Zhang, P., Huang, X., Yu, M., Murphy, J., Michalak, E., Liu, J., Yang, T., Yang, X., Fang, Y., Lam, R., & Chen, J. (2024). Comparison of the Efficacy Between Standard Measurement-Base Care (MBC) and Enhanced MBC for Major Depressive Disorder: A Pilot Study. Neuropsychiatric Disease and Treatment, Volume 20, 1465–1473. https://doi.org/10.2147/ndt.s468332Links to an external site..
Kendrick, T., Dowrick, C., Lewis, G., Moore, M., Leydon, G. M., Geraghty, A. W., Griffiths, G., Zhu, S., Yao, G. L., May, C., Gabbay, M., Dewar-Haggart, R., Williams, S., Bui, L., Thompson, N., Bridewell, L., Trapasso, E., Patel, T., McCarthy, M., & Khan, N. (2024). Depression follow-up monitoring with the PHQ-9: an open cluster-randomised controlled trial. British Journal of General Practice, 74(744), BJGP.2023.0539–BJGP.2023.0539. https://doi.org/10.3399/bjgp.2023.0539Links to an external site..
Kilian, A., Upton, L. A., & Sheagren, J. N. (2020). Reorganizing the History of Present Illness to Improve Verbal Case Presenting and Clinical Diagnostic Reasoning Skills of Medical Students: The All-Inclusive History of Present Illness. Journal of Medical Education and Curricular Development, 7. https://doi.org/10.1177/2382120520928996Links to an external site..
Kim, S., Lee, H.-K., & Lee, K. (2021). Which PHQ-9 Items Can Effectively Screen for Suicide? Machine Learning Approaches. International Journal of Environmental Research and Public Health, 18(7), 3339. https://doi.org/10.3390/ijerph18073339Links to an external site..
Levis, B., Benedetti, A., Ioannidis, J. P. A., Sun, Y., Negeri, Z., He, C., Wu, Y., Krishnan, A., Bhandari, P. M., Neupane, D., Imran, M., Rice, D. B., Riehm, K. E., Saadat, N., Azar, M., Boruff, J., Cuijpers, P., Gilbody, S., Kloda, L. A., & McMillan, D. (2020). Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. Journal of Clinical Epidemiology, 122, 115-128.e1. https://doi.org/10.1016/j.jclinepi.2020.02.002Links to an external site..
Ryan, E. P., & Oquendo, M. A. (2020). Suicide Risk Assessment and Prevention: Challenges and Opportunities. FOCUS the Journal of Lifelong Learning in Psychiatry, 18(2), 88–99. https://doi.org/10.1176/appi.focus.20200011Links to an external site.. .
Teusen, C., Hapfelmeier, A., von Schrottenberg, V., Gökce, F., Pitschel-Walz, G., Henningsen, P., Gensichen, J., & Schneider, A. (2022). Combining the GP’s assessment and the PHQ-9 questionnaire leads to more reliable and clinically relevant diagnoses in primary care. PLOS ONE, 17(10), e0276534. https://doi.org/10.1371/journal.pone.0276534
Patient Health Questionnaire-9 (PHQ-9) Psychiatric Evaluation and Evidence-Based Rating Scale Sample 2
A comprehensive psychiatric interview is essential for accurate diagnosis, treatment planning and ongoing management of mental health disorders. The interview provides the Psychiatric-Mental Health Nurse Practitioner (PMHNP) with critical information regarding a patient’s symptoms, functioning and psychosocial circumstances. Three important components of the psychiatric interview are the history of present illness (HPI), mental status examination (MSE) and psychiatric history.
The history of present illness (HPI) is a vital component because it provides a detailed description of the patient’s current symptoms, including onset, duration, severity, precipitating factors and impact on daily functioning. A thorough HPI allows the clinician to identify symptom patterns, assess functional impairment and differentiate among psychiatric diagnoses that may present with similar symptoms (Boland et al., 2022). Understanding the patient’s current concerns is essential for developing an appropriate treatment plan and establishing therapeutic goals.
The mental status examination (MSE) is another important aspect of the psychiatric interview. The MSE provides a structured assessment of a patient’s appearance, behavior, speech, mood, affect, thought processes, thought content, cognition, insight and judgment. Unlike the HPI, which relies on patient self-report, the MSE allows the clinician to directly observe the patient’s current psychological functioning. Findings from the MSE help identify symptoms associated with mood disorders, psychosis, cognitive impairment and safety concerns, such as suicidal ideation (Carlat, 2024).
A third essential component is the psychiatric history, which includes previous psychiatric diagnoses, hospitalizations, medication trials, substance use history, trauma exposure and family psychiatric history. Obtaining a comprehensive psychiatric history helps identify genetic predispositions, previous treatment responses and risk factors that may influence the patient’s current presentation. Family psychiatric history is especially important because many psychiatric disorders demonstrate hereditary patterns and increased familial risk (Boland et al., 2022).
One evidence-based rating scale commonly used in psychiatric practice is the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a self-administered screening tool designed to assess depressive symptoms based on the diagnostic criteria for major depressive disorder. The instrument contains nine questions that evaluate symptom frequency during the previous two weeks and provides a severity score ranging from 0 to 27. Higher scores indicate greater symptom severity and may suggest the need for further psychiatric evaluation (Costantini et al., 2021).
The PHQ-9 demonstrates strong psychometric properties, including high reliability, validity, sensitivity and specificity for identifying major depressive disorders. Costantini et al. (2021) found that the PHQ-9 is highly effective as a screening instrument in both primary care and mental health settings. Similarly, Levis et al. (2019) reported that the PHQ-9 accurately identifies patients with major depression and performs well across diverse populations. More recently, Negeri et al. (2021) conducted an updated systematic review and meta-analysis and confirmed PHQ-9’s strong diagnostic accuracy, supporting its continued use as a reliable depression screening tool.
The PHQ-9 is appropriate for use when patients present with symptoms such as persistent sadness, loss of interest in activities, sleep disturbances, appetite changes, fatigue, poor concentration or feelings of hopelessness. PMHNPs can administer PHQ-9 during an initial psychiatric evaluation to screen for depression and establish baseline symptom severity. The tool may also be used throughout treatment to monitor symptom progression and evaluate treatment effectiveness. By providing objective and standardized data, PHQ-9 assists PMHNPs in clinical decision-making, enhances communication among healthcare providers and supports evidence-based treatment planning (Costantini et al., 2021; Negeri et al., 2021).
In conclusion, the history of present illness, mental status examination and psychiatric history are essential components of a comprehensive psychiatric interview because they provide valuable information necessary for accurate diagnosis and treatment planning. The PHQ-9 is a reliable and valid evidence-based screening instrument that helps PMHNPs identify, assess and monitor depressive symptoms. Combining a thorough psychiatric evaluation with standardized rating scales promotes evidence-based practice and improves patient outcomes.
References
Boland, R., Verduin, M. L., & Ruiz, P. (2022). Kaplan & Sadock’s synopsis of psychiatry (12th ed.). Wolters Kluwer.
Carlat, D. J. (2024). The psychiatric interview (5th ed.). Wolters Kluwer.
Costantini, L., Pasquarella, C., Odone, A., Colucci, M. E., Costanza, A., Serafini, G., Aguglia, A., Belvederi Murri, M., Brakoulias, V., Ghaemi, S. N., & Amerio, A. (2021). Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review. Journal of Affective Disorders, 279, 473–483. https://doi.org/10.1016/j.jad.2020.09.131Links to an external site.
Levis, B., Benedetti, A., Thombs, B. D., & DEPRESsion Screening Data (DEPRESSD) Collaboration. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ, 365, l1476. https://doi.org/10.1136/bmj.l1476Links to an external site.
Negeri, Z. F., Levis, B., Sun, Y., He, C., Krishnan, A., Wu, Y., Bhandari, P. M., Neupane, D., Brehaut, E., Benedetti, A., Thombs, B. D., & Depression Screening Data (DEPRESSD) PHQ Group. (2021). Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: Updated systematic review and individual participant data meta-analysis. BMJ, 375, n2183. https://doi.org/10.1136/bmj.n2183
Patient Health Questionnaire-9 (PHQ-9) Psychiatric Evaluation and Evidence-Based Rating Scale Sample 3
Three Essential Components of the Psychiatric Interview and the Use of the PHQ-9
The psychiatric interview is a fundamental part of mental health assessment because it helps clinicians understand a patient’s symptoms, experiences, and overall functioning. Beyond gathering information, the interview provides an opportunity to build trust and establish a therapeutic relationship. Several components contribute to a comprehensive psychiatric evaluation; however, the history of present illness, mental status examination, and suicide/risk assessment are particularly important because they provide critical information for diagnosis, treatment planning, and patient safety.
History of Present Illness
The history of present illness (HPI) is often the starting point for understanding why a patient is seeking care. During this portion of the interview, the clinician explores the patient’s current symptoms, when they began, factors that may have contributed to them, and how the symptoms affect daily life. Information about previous treatments, coping strategies, and symptom progression is also gathered.
I believe the HPI is especially important because it allows the provider to hear the patient’s story in their own words. This information helps identify patterns and possible diagnoses while also providing insight into how mental health concerns are impacting the individual’s relationships, work, school, and overall quality of life. A thorough HPI creates the foundation for developing an individualized treatment plan that addresses the patient’s unique needs (Carlat, 2024).
Mental Status Examination
Another key component of the psychiatric interview is the mental status examination (MSE). The MSE provides a structured assessment of the patient’s current psychological functioning by evaluating appearance, behavior, speech, mood, affect, thought processes, cognition, insight, and judgment.
The MSE is important because it offers objective information that may either support or challenge what is reported during the interview. For example, a patient may describe feeling fine, but observations of poor eye contact, slowed speech, or a flat affect may indicate underlying depression. The MSE also helps identify serious conditions such as psychosis, mania, or cognitive impairment that may require immediate intervention. By documenting these findings over time, clinicians can monitor progress and evaluate treatment effectiveness (Sadock et al., 2023).
Suicide and Risk Assessment
Assessing for suicide risk and other safety concerns is one of the most critical responsibilities during a psychiatric evaluation. This assessment includes asking about suicidal thoughts, self-harm behaviors, homicidal ideation, substance use, and access to potentially lethal means.
This component is essential because patient safety must always be the highest priority. Mental health providers cannot assume that patients will voluntarily disclose suicidal thoughts unless directly asked. A comprehensive risk assessment helps identify individuals who may need additional support, crisis intervention, safety planning, or emergency treatment. Early identification of safety concerns can significantly reduce the risk of harm and improve patient outcomes (American Psychiatric Association, 2024).
The PHQ-9 and Its Clinical Value
The Patient Health Questionnaire-9 (PHQ-9) is one of the most commonly used screening tools for depression in both primary care and mental health settings. The questionnaire contains nine items that reflect the symptoms of major depressive disorder and asks patients to report how frequently they have experienced each symptom during the previous two weeks.
The PHQ-9 has strong psychometric properties and has been shown to be both reliable and valid for identifying depression. Research by Kroenke et al. (2001) demonstrated that the tool has high sensitivity and specificity when used to screen for major depressive disorder. Additionally, a large meta-analysis confirmed its effectiveness across diverse patient populations and healthcare settings (Levis et al., 2019).
Appropriate Use of the PHQ-9
The PHQ-9 is appropriate when patients present with symptoms commonly associated with depression, such as persistent sadness, fatigue, sleep disturbances, difficulty concentrating, or loss of interest in activities. It can also be used as part of routine screening programs in primary care, behavioral health clinics, and community health settings.
One advantage of the PHQ-9 is that it is not limited to initial screening. The scale can be administered repeatedly throughout treatment to monitor symptom severity and evaluate patient response to therapy or medication. This allows clinicians to make evidence-based decisions regarding treatment modifications when necessary.
How the PHQ-9 Can Be Helpful in Practice
As a future psychiatric mental health nurse practitioner, I see the PHQ-9 as a valuable tool because it provides a standardized method for assessing depressive symptoms. While it does not replace a comprehensive clinical assessment, it helps support clinical judgment by offering measurable data regarding symptom severity.
The PHQ-9 can also improve communication among healthcare providers by creating a consistent way to document and track patient progress. Because it is brief, easy to administer, and easy for patients to understand, it can be incorporated into routine practice without significantly increasing workload. Most importantly, the tool can facilitate early identification of depression, allowing providers to intervene before symptoms worsen and negatively affect a patient’s functioning and quality of life.
References
American Psychiatric Association. (2024). Practice guideline for the assessment and treatment of patients with suicidal behaviors. American Psychiatric Association.
Carlat, D. J. (2024). The psychiatric interview (5th ed.). Wolters Kluwer.
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.xLinks to an external site.
Levis, B., Benedetti, A., & Thombs, B. D. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ, 365, l1476. https://doi.org/10.1136/bmj.l1476Links to an external site.
Sadock, B. J., Sadock, V. A., & Ruiz, P. (2023). Kaplan & Sadock’s synopsis of psychiatry (12th ed.). Wolters Kluwer. Patient Health Questionnaire-9 (PHQ-9) Psychiatric Evaluation and Evidence-Based Rating Scale